Medgenics Announces Exercise by Underwriters of Over-Allotment Option

[Business Wire] – Medgenics, Inc. , the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that, in connection with its previously announced publi more

View todays social media effects on MDGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Medgenics is hiring next, click here to view